These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32090179)

  • 1. Arabinosyltransferase C enzyme of
    Das N; Jena PK; Pradhan SK
    Heliyon; 2020 Feb; 6(2):e02693. PubMed ID: 32090179
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Jagadeb M; Rath SN; Sonawane A
    J Biomol Struct Dyn; 2019 Aug; 37(13):3388-3398. PubMed ID: 30132739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigation of Efflux Pump Genes in Resistant Mycobacterium tuberculosis Complex Clinical Isolates Exposed to First Line Antituberculosis Drugs and Verapamil Combination].
    Özgür D; Ersoy L; Ülger M; Tezcan Ülger S; Aslan G
    Mikrobiyol Bul; 2023 Apr; 57(2):207-219. PubMed ID: 37067206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution patterns of drug resistance Mycobacterium tuberculosis among HIV negative and positive tuberculosis patients in Western Kenya.
    Ogwang MO; Imbuga M; Ngugi C; Mutharia L; Magoma G; Diero L
    BMC Infect Dis; 2021 Nov; 21(1):1175. PubMed ID: 34809602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of mechanism of interaction of truncated isoniazid-nicotinamide adenine dinucleotide adduct against multiple enzymes of Mycobacterium tuberculosis by a computational approach.
    Jena L; Deshmukh S; Waghmare P; Kumar S; Harinath BC
    Int J Mycobacteriol; 2015 Dec; 4(4):276-83. PubMed ID: 26964808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tubercular Modelling via QSAR Approach, In Silico Design and Virtual Docking Screening of Designed Hypothetical Inhibitors Against DNA gyrase Protein.
    Adeniji SE
    Curr Comput Aided Drug Des; 2021; 17(6):739-758. PubMed ID: 32586260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanism of the synergistic activity of ethambutol and isoniazid against
    Zhu C; Liu Y; Hu L; Yang M; He ZG
    J Biol Chem; 2018 Oct; 293(43):16741-16750. PubMed ID: 30185616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular insights of hyaluronic acid - ethambutol and hyaluronic acid - isoniazid drug conjugates act as promising novel drugs for the treatment of tuberculosis.
    Thirumalaisamy R; Aroulmoji V; Iqbal MN; Saride S; Bhuvaneswari M; Deepa M; Sivasankar C; Khan R
    J Biomol Struct Dyn; 2023 May; 41(8):3562-3573. PubMed ID: 35293842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantum modelling and molecular docking evaluation of some selected quinoline derivatives as anti-tubercular agents.
    Adeniji SE; Adamu Shallangwa G; Ebuka Arthur D; Abdullahi M; Mahmoud AY; Haruna A
    Heliyon; 2020 Mar; 6(3):e03639. PubMed ID: 32258484
    [No Abstract]   [Full Text] [Related]  

  • 12. The Effects Study of Isoniazid Conjugated Multi-Wall Carbon Nanotubes Nanofluid on
    Zomorodbakhsh S; Abbasian Y; Naghinejad M; Sheikhpour M
    Int J Nanomedicine; 2020; 15():5901-5909. PubMed ID: 32884258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the MeltPro TB assay and whole-genome sequencing assay for rapid molecular diagnosis of drug resistant tuberculosis in guangdong province.
    Yu M; Zhang C; Xu L; Peng K; Qiu H; Zhuo W; Zhao Y; Wu Z; Chen X; Chen Y; Liao Q; Huang Y; Wei W
    Diagn Microbiol Infect Dis; 2024 Feb; 108(2):116128. PubMed ID: 38007912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The arabinosyltransferase EmbC is inhibited by ethambutol in Mycobacterium tuberculosis.
    Goude R; Amin AG; Chatterjee D; Parish T
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4138-46. PubMed ID: 19596878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular detection of Isoniazid, Rifampin and Ethambutol resistance to M. tuberculosis and M. bovis in multidrug resistant tuberculosis (MDR-TB) patients in Pakistan.
    Munir S; Mahmood N; Shahid S; Khan MI
    Microb Pathog; 2017 Sep; 110():262-274. PubMed ID: 28688981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidating the function of hypothetical PE_PGRS45 protein of
    Medha ; Joshi H; Sharma S; Sharma M
    J Biomol Struct Dyn; 2023 Nov; 41(19):10009-10025. PubMed ID: 36448553
    [No Abstract]   [Full Text] [Related]  

  • 18. Ethambutol targets the glutamate racemase of Mycobacterium tuberculosis-an enzyme involved in peptidoglycan biosynthesis.
    Pawar A; Jha P; Konwar C; Chaudhry U; Chopra M; Saluja D
    Appl Microbiol Biotechnol; 2019 Jan; 103(2):843-851. PubMed ID: 30456576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homology modeling and molecular docking simulation of some novel imidazo[1,2-a]pyridine-3-carboxamide (IPA) series as inhibitors of Mycobacterium tuberculosis.
    Abdullahi M; Adeniji SE; Arthur DE; Haruna A
    J Genet Eng Biotechnol; 2021 Jan; 19(1):12. PubMed ID: 33474593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.